Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Athanasios Fassas

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
JAMA Neurology|February 28, 2017
Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple SclerosisPaolo A Muraro, Marcelo Pasquini, Harold L Atkins, et al.
The Lancet. Oncology|April 7, 2009
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II studyFabio Ciceri, Chiara Bonini, Maria Teresa Lupo Stanghellini, et al.
JAMA|July 25, 2014
Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trialJacob M van Laar, Dominique Farge, Jacob K Sont, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
JAMA Neurology|February 28, 2017
Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple SclerosisPaolo A Muraro, Marcelo Pasquini, Harold L Atkins, et al.
The Lancet. Oncology|April 7, 2009
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II studyFabio Ciceri, Chiara Bonini, Maria Teresa Lupo Stanghellini, et al.
JAMA|July 25, 2014
Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trialJacob M van Laar, Dominique Farge, Jacob K Sont, et al.
Pageof 6